RAJABABU KURRE: Open Payments
NPI 1376584680 · REDLANDS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 8 payments from 6 companies in 2025. Trend: 2023 $126 · 2024 $414 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $58 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| Lundbeck LLC | 1 | $25 |
| ABBVIE INC. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: COBENFY, INVEGA SUSTENNA, CAPLYTA, REXULTI, VRAYLAR, INGREZZA.
Industry payments across CA — which companies pay providers there.
